Relations (1)
cross_type 2.00 — strongly supporting 3 facts
South Korea is linked to pharmaceuticals through trade agreements and tariff policies, as evidenced by exemptions for pharmaceutical products [1], modifications to sectoral tariffs on these goods [2], and subsequent tariff increases imposed on pharmaceutical imports from the country [3].
Facts (3)
Sources
Tracking Trump's Trade Deals | Council on Foreign Relations cfr.org 3 facts
claimThe trade agreement between the United States and South Korea modifies the application of Section 232 sectoral tariffs on autos, auto parts, lumber, pharmaceuticals, timber, and wood derivatives, capping the rate at 15 percent to match the new baseline tariff.
claimSouth Korea received exemptions from reciprocal tariffs on select products unavailable in the United States, specifically natural resources, pharmaceutical products, and certain aircraft and parts.
quoteOn January 26, 2026, President Donald Trump accused South Korea’s legislature of “not living up to its Deal with the United States,” and raised tariffs on imports of autos, lumber, pharmaceuticals, and all other reciprocal tariffs to 25 percent.